You are here

  • Home
  • Archive
  • Volume 6, Issue 1
  • Hydroxychloroquine usage in US patients, their experiences of tolerability and adherence, and implications for treatment: survey results from 3127 patients with SLE conducted by the Lupus Foundation of America

Article metrics

Article menu

Download PDFPDF

Brief communication
Hydroxychloroquine usage in US patients, their experiences of tolerability and adherence, and implications for treatment: survey results from 3127 patients with SLE conducted by the Lupus Foundation of America

 

Online download statistics by month:

Online download statistics by month: March 2019 to March 2024

AbstractFullPdf
Mar 2019685667104
Apr 2019612605116
May 201934433264
Jun 201924624446
Jul 201924724534
Aug 201923323129
Sep 201916115520
Oct 201914514134
Nov 2019979325
Dec 201911411313
Jan 202010510314
Feb 202011911416
Mar 202071270946
Apr 202019181911726
May 202016311628187
Jun 202018618438
Jul 202050450372
Aug 202022122046
Sep 202011811415
Oct 202011811614
Nov 202053536
Dec 202052534
Jan 2021777516
Feb 2021615914
Mar 2021797816
Apr 202171697
May 2021706912
Jun 202121621515
Jul 2021343219
Aug 2021474624
Sep 2021504824
Oct 2021625838
Nov 2021383822
Dec 2021414010
Jan 2022525110
Feb 2022605815
Mar 202228271
Apr 202237354
May 2022535012
Jun 2022444213
Jul 202230295
Aug 202242419
Sep 2022424210
Oct 2022565410
Nov 2022444217
Dec 2022383915
Jan 202343398
Feb 2023565613
Mar 202341416
Apr 202331285
May 202337347
Jun 202325252
Jul 202329269
Aug 202341436
Sep 2023414210
Oct 202327271
Nov 202330304
Dec 2023323010
Jan 2024202011
Feb 2024474711
Mar 2024322827
Total10525103872137